[1] |
Kissebah, AH, Sonnenberg, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome Proc Natl Acad Sci USA, 97 (2000),pp. 14478-14483
|
[2] |
Berg, AH, Combs, et al. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat Med, 7 (2001),pp. 947-953
|
[3] |
Fruebis, J, Tsao, et al. Proteolytic cleavage product of 30 kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc Natl Acad Sci USA, 98 (2001),pp. 2005-2010
|
[4] |
Yamauchi, T, Kamon, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis J Biol Chem, 278 (2003),pp. 2461-2468
|
[5] |
Kissebah, AH, Sonnenberg, et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome Proc Natl Acad Sci USA, 97 (2000),pp. 14478-14483
|
[6] |
Francke, S, Manraj, et al. A genome-wide scan for coronary heart disease suggests in Indo-Mauritians a susceptibility locus on chromosome 16p13 and replicates linkage with the metabolic syndrome on 3q27 Hum Mol Genet, 10 (2001),pp. 2751-2765
|
[7] |
Bahia, L, Aguiar, et al. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome Clinics, 61 (2006),pp. 433-440
|
[8] |
Ouchi, N, Kihara, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin Circulation, 100 (1999),pp. 2473-2476
|
[9] |
Ouchi, N, Kihara, et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages Circulation, 103 (2001),pp. 1057-1063
|
[10] |
Nakatani, K, Noma, et al. Adiponectin gene variation associates with the increasing risk of type 2 diabetes in non-diabetic Japanese subjects Int J Mol Med, 15 (2005),pp. 173-177
|
[11] |
Zacharova, J, Chiasson, et al. The common polymorphisms (single nucleotide polymorphism [SNP] +45 and SNP +276) of the adiponectin gene predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM trial Diabetes, 54 (2005),pp. 893-899
|
[12] |
Filippi, E, Sentinelli, et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age <or=50 years) J Mol Med, 83 (2005),pp. 711-719
|
[13] |
Liu, H, Zhang, et al. Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese Metabolism, 54 (2005),pp. 568-572
|
[14] |
Su, Z, Zhang, et al. A novel allele in the promoter of the hepatic lipase is associated with increased concentration of HDL-C and decreased promoter activity J Lipid Res, 43 (2002),pp. 1595-1601
|
[15] |
World health organization. Definition, diagnosis and classification of diabetes mellitus and its complications report of WHO consultation Part 1: diagnosis and classification of diabetes mellitus. Geneva, 1999.
|
[16] |
Matthews, DR, Hosker, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia, 28 (1985),pp. 412-419
|
[17] |
Hotta, K, Funahashi, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients Arterioscler Thromb Vasc Biol, 20 (2000),pp. 1595-1599
|
[18] |
Kubota, N, Terauchi, et al. Disruption of adiponectin causes insulin resistance and neointimal formation J Biol Chem, 277 (2002),pp. 25863-25866
|
[19] |
Yamauchi, T, Kamon, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects Nature, 423 (2003),pp. 762-769
|
[20] |
Matsuzawa, Y Adiponectins and metabolic syndrome Semin Vasc Med, 5 (2005),pp. 34-39
|
[21] |
Arita, Y, Kihara, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity Biochem Biophys Res Commun, 257 (1999),pp. 79-83
|
[22] |
Iacobellis, G, Pistilli, et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease Cytokine, 29 (2005),pp. 251-255
|
[23] |
Yang, X, Jansson, et al. Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity Obes Res, 13 (2005),pp. 813-817
|
[24] |
Gonzalez-Sanchez, JL, Zabena, et al. An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance Obes Res, 13 (2005),pp. 807-812
|
[25] |
Kondo, H, Shimomura, et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome Diabetes, 51 (2002),pp. 2325-2328
|
[26] |
Hara, K, Boutin, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population Diabetes, 51 (2002),pp. 536-540
|
[27] |
Xia, H, Mo, et al. Correlation between single nucleotide polymorphism of adiponectin gene and type 2 diabetes in Chinese Chin J Endocrinol Metab, 20 (2004),pp. 236-237
|
[28] |
Lee, YY, Lee, et al. Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population Diabet Med, 22 (2005),pp. 569-575
|
[29] |
Ohashi, K, Ouchi, et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease J Am Coll Cardiol, 43 (2004),pp. 1195-1200
|
[30] |
Lacquemant, C, Froguel, et al. The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non-insulin-dependent) diabetes mellitus Diabet Med, 21 (2004),pp. 776-781
|
[31] |
Filippi, E, Sentinelli, et al. The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age <or=50 years) J Mol Med, 83 (2005),pp. 711-719
|